IMC Microwave Industries Overview
IMC Industries specializes in developing & manufacturing state-of-the-art RF modules, microwave components and data link communication systems for defense, homeland security and civilian applications. IMC's products are integrated as part of various Ground, Air, Space and Maritime platforms and applications around the world.The company's products are based on the latest technology available in the market integrated with its own internal innovations that are based on an invaluable combination of client variety and years of experience
Latest News
growth-positive
/CNW/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, today announced...
IM Cannabis Corp., a leading medical cannabis company operating in Israel and Germany, has announced significant changes to its Board of Directors. Effective September 15, 2025, Shmulik Arbel and Brian Schinderle have resigned, and Asaf Yitzhaik and Eli Zamir have been appointed to fill their positions. Additionally, Oz Adler has been appointed as the new Chairman of the Board. The company is exploring new business activities to enhance long-term growth and shareholder value. IM Cannabis is committed to leveraging its transnational ecosystem and data-driven approach to strengthen its position in the medical cannabis markets of Israel and Germany.
Management Changes
growth-positive
/PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, today...
IM Cannabis Corp., a leading medical cannabis company operating in Israel and Germany, announced significant changes to its Board of Directors. Effective September 15, 2025, Shmulik Arbel and Brian Schinderle resigned, with Asaf Yitzhaik and Eli Zamir appointed to fill their positions. Additionally, Oz Adler was appointed as the new Chairman of the Board. The company is exploring new business activities to enhance long-term growth and shareholder value. IM Cannabis focuses on providing premium cannabis products to medical patients in Israel and Germany, leveraging a data-driven approach and a global supply chain. The company aims to amplify its commercial and brand power while complying with strict regulatory environments.
Management Changes
growth-positive
/CNW/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today for the...
IM Cannabis Corp. reported strong financial results for Q2 2025, despite facing external challenges such as the ongoing war in Israel and supply chain delays. The company experienced a 14% decrease in revenue compared to Q2 2024, primarily due to decreased revenue in Israel. However, it achieved a 306% increase in gross profit and a 371% increase in gross margin. The companys EBITDA improved significantly, turning a profit of $0.1 million from a loss of $2.3 million in the previous year. The management remains optimistic about recovering the revenue impact in the coming quarters and is focused on sustainable growth.
growth-positive
/PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today for...
IM Cannabis Corp. reported strong financial results for Q2 2025, despite a 14% revenue decline compared to Q2 2024, attributed to external challenges such as the ongoing war in Israel and supply chain delays. The company achieved a 306% increase in gross profit and a 371% increase in gross margin, reflecting disciplined cost management and operational efficiency. The EBITDA turned positive with a profit of $0.1 million, compared to a loss of $2.3 million in the previous year. The company remains focused on sustainable growth and expects to recover the revenue impact in the coming quarters.
growth-positive
/CNW/ -- IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany,...
IM Cannabis Corp., a leading medical cannabis company with operations in Israel and Germany, is set to report its operational and financial results for the second quarter of 2025 on August 12, 2025. The company focuses on sustainable and profitable growth in its key markets, leveraging a data-driven approach and a globally sourced product supply chain. IMC operates through subsidiaries in Israel, providing cannabis to medical patients and managing retail pharmacies, online platforms, and distribution centers. In Germany, it distributes cannabis to pharmacies through Adjupharm GmbH. The companys commitment to responsible growth and compliance aims to enhance its commercial and brand power globally.
| Sector | Aerospace, Defense & HLS |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Mature |
| Rounds | 0 |
| Investors | 0 |
Team Members
2
Employees: 11-50
Web & Social Links
| Website | www.imc-mw.com |
Locations
Nakhshon St 6, Petah Tikva, Israel
Photos & Videos
No files yet
IMC Microwave Industries Business
Business models
B2G, B2B
Product stage
Released
Employees
11-50
Sector
Aerospace, Defense & HLSDefense & HLS SolutionsDefense ElectronicsUnmanned SystemsTarget Customer
Defense, Safety & SecurityNational SecurityCivilMilitarySecurityHomeland SecurityCore Technology
CommunicationsRadio FrequencyTags (11)
unmanned-aerial-vehicleaerospacedefensehomeland-securityrf-technologyantennasunmanned-ground-vehicleelectronicscommunicationsmarinedual-useIMC Microwave Industries Financials
Undisclosed
Total funding
—
Capital raised
Undisclosed
Last funding
Mature
Funding stage
0
Total rounds
0
Investors
IMC Microwave Industries Lifecycle
IMC Microwave Industries News
8 articles
growth-positive
/CNW/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, today announced...
IM Cannabis Corp., a leading medical cannabis company operating in Israel and Germany, has announced significant changes to its Board of Directors. Effective September 15, 2025, Shmulik Arbel and Brian Schinderle have resigned, and Asaf Yitzhaik and Eli Zamir have been appointed to fill their positions. Additionally, Oz Adler has been appointed as the new Chairman of the Board. The company is exploring new business activities to enhance long-term growth and shareholder value. IM Cannabis is committed to leveraging its transnational ecosystem and data-driven approach to strengthen its position in the medical cannabis markets of Israel and Germany.
Management Changes
growth-positive
/PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, today...
IM Cannabis Corp., a leading medical cannabis company operating in Israel and Germany, announced significant changes to its Board of Directors. Effective September 15, 2025, Shmulik Arbel and Brian Schinderle resigned, with Asaf Yitzhaik and Eli Zamir appointed to fill their positions. Additionally, Oz Adler was appointed as the new Chairman of the Board. The company is exploring new business activities to enhance long-term growth and shareholder value. IM Cannabis focuses on providing premium cannabis products to medical patients in Israel and Germany, leveraging a data-driven approach and a global supply chain. The company aims to amplify its commercial and brand power while complying with strict regulatory environments.
Management Changes
growth-positive
/CNW/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today for the...
IM Cannabis Corp. reported strong financial results for Q2 2025, despite facing external challenges such as the ongoing war in Israel and supply chain delays. The company experienced a 14% decrease in revenue compared to Q2 2024, primarily due to decreased revenue in Israel. However, it achieved a 306% increase in gross profit and a 371% increase in gross margin. The companys EBITDA improved significantly, turning a profit of $0.1 million from a loss of $2.3 million in the previous year. The management remains optimistic about recovering the revenue impact in the coming quarters and is focused on sustainable growth.
growth-positive
/PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today for...
IM Cannabis Corp. reported strong financial results for Q2 2025, despite a 14% revenue decline compared to Q2 2024, attributed to external challenges such as the ongoing war in Israel and supply chain delays. The company achieved a 306% increase in gross profit and a 371% increase in gross margin, reflecting disciplined cost management and operational efficiency. The EBITDA turned positive with a profit of $0.1 million, compared to a loss of $2.3 million in the previous year. The company remains focused on sustainable growth and expects to recover the revenue impact in the coming quarters.
growth-positive
/CNW/ -- IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany,...
IM Cannabis Corp., a leading medical cannabis company with operations in Israel and Germany, is set to report its operational and financial results for the second quarter of 2025 on August 12, 2025. The company focuses on sustainable and profitable growth in its key markets, leveraging a data-driven approach and a globally sourced product supply chain. IMC operates through subsidiaries in Israel, providing cannabis to medical patients and managing retail pharmacies, online platforms, and distribution centers. In Germany, it distributes cannabis to pharmacies through Adjupharm GmbH. The companys commitment to responsible growth and compliance aims to enhance its commercial and brand power globally.
growth-positive
/PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and...
IM Cannabis Corp., a leading medical cannabis company with operations in Israel and Germany, is set to report its operational and financial results for the second quarter of 2025 on August 12, 2025. The company focuses on providing premium cannabis products to medical patients in two of the largest medical cannabis markets, Israel and Germany. IM Cannabis aims for sustainable and profitable growth by leveraging a transnational ecosystem powered by a data-driven approach and a globally sourced product supply chain. The company operates through subsidiaries in Israel and Adjupharm GmbH in Germany, distributing cannabis to pharmacies and medical patients.
growth-positive
/PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased...
IM Cannabis Corp., a leading medical cannabis company operating in Israel and Germany, has appointed Mr. Oz Adler to its board of directors. This appointment is part of a loan agreement with L.I.A. Pure Capital Ltd., which provided IM Cannabis with an initial loan of USD 1 million, with the potential for an additional USD 1 million. The company aims to raise at least USD 3 million through an underwritten offering. Mr. Adlers extensive experience in capital markets and pharmaceutical ventures is expected to support IM Cannabiss strategic growth and profitability. The company is focused on expanding its footprint in the medical cannabis markets of Israel and Germany.
Management ChangesInvestment
growth-positive
/CNW/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to...
IM Cannabis Corp. has appointed Mr. Oz Adler to its board of directors, effective July 6, 2025, as part of a loan agreement with L.I.A. Pure Capital Ltd. The company received a $1 million loan tranche, with a potential second tranche of the same amount by September 4, 2025. The loan is secured by a pledge over shares of IMC Holdings Ltd. and carries an 8% annual interest rate. IM Cannabis aims to raise $3 million within 60 days through an underwritten offering. Mr. Adlers appointment and financial expertise are expected to support the companys strategic growth in Israel and Germany.
Management ChangesInvestment
IMC Microwave Industries Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 16 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 13 classification IDs that could be used for matching.
IMC Microwave Industries Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 79/100 |
| Missing | sector, video or image, funding rounds, news, markets, not claimed |
| BI Verification | Ayelet Levi Shinebox |
| Registrar ID | 511163461 |
| Phone | 039300464 |
| Creator | Ayelet Levi Shinebox |
| Creator email | ayeletlevis@sncentral.org |
| Last updater | Ayelet Levi Shinebox |
| Updater email | ayeletlevis@sncentral.org |
| Last update | 2024-08-11T00:00:00.000Z |
| Created | 2024-03-25T00:00:00.000Z |